Serina Therapeutics SER
NYSE SER
$1.78 +0.01 (+0.56%)
As of: Oct 22, 2026 · 2:35 PM EDT

Serina Therapeutics (SER) Return on Equity [ROE] (2018 - 2026)

Updated

Serina Therapeutics' Return on Equity [ROE] came in at -222.00% for Q2 2026, up 567.58 percentage points from -789.58% a year earlier.

Analysis

Serina Therapeutics (SER) Return on Equity [ROE] (2018 - 2026) Analysis & Trends

For FY2025, Serina Therapeutics' Return on Equity [ROE] was -8159.24%.

  • The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 19.33%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 7.21%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 31.52%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 21.39%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -18.38%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.97%
10 Serina Therapeutics 29.17 Mn -11.58 Mn - -222.00%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -222.00%
Dec 31, 2025 -2,230.41%
Sep 30, 2025 -1,094.01%
Jun 30, 2025 -789.58%
Mar 31, 2025 -98.11%
Mar 31, 2020 -1,105.71%
Dec 31, 2019 -327.62%
Sep 30, 2019 -209.18%
Jun 30, 2019 -135.65%
Mar 31, 2019 -116.34%
Dec 31, 2018 -81.52%
API Access

Serina Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SER&period=max&api_key=YOUR_API_KEY